Guus F Rimmelzwaan Selected Research

B 956

7/2008

DC-SIGN enhances infection of cells with glycosylated West Nile virus in vitro and virus replication in human dendritic cells induces production of IFN-alpha and TNF-alpha.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guus F Rimmelzwaan Research Topics

Disease

60	Human Influenza (Influenza) 11/2021 - 02/2004
57	Infections 01/2021 - 02/2004
12	Influenza in Birds (Avian Flu) 01/2016 - 03/2005
5	Inflammation (Inflammations) 01/2019 - 01/2006
5	Virus Diseases (Viral Diseases) 01/2019 - 03/2012
3	Pneumonia (Pneumonitis) 03/2015 - 01/2013
2	COVID-19 12/2021 - 01/2021
2	Neoplasms (Cancer) 12/2021 - 01/2019
2	Asthma (Bronchial Asthma) 01/2019 - 02/2004
2	West Nile Fever 04/2011 - 01/2008
1	Dengue (Dengue Fever) 06/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Multiple Myeloma 01/2020
1	Myasthenia Gravis 01/2019
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2019
1	Vesicular Stomatitis 01/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018
1	Respiratory Tract Diseases (Respiratory Tract Disease) 07/2014
1	Tuberculosis (Tuberculoses) 05/2013
1	Disease Resistance 03/2013
1	Sarcoidosis (Schaumann Disease) 02/2013
1	Orthomyxoviridae Infections 10/2012
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2012
1	Coinfection 07/2010
1	Conjunctivitis 02/2010

Drug/Important Bio-Agent (IBA)

43	VaccinesIBA 08/2020 - 02/2004
19	AntibodiesIBA 10/2019 - 07/2004
16	Hemagglutinins (Hemagglutinin)IBA 01/2018 - 12/2004
14	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2004
11	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2020 - 12/2004
9	AntigensIBA 01/2019 - 03/2004
8	Antiviral Agents (Antivirals)IBA 01/2019 - 04/2005
7	Neuraminidase (Sialidase)IBA 11/2021 - 01/2010
7	EpitopesIBA 01/2018 - 02/2004
6	Neutralizing AntibodiesIBA 01/2018 - 01/2008
4	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2019 - 01/2011
3	Peptides (Polypeptides)IBA 01/2020 - 07/2010
3	Pharmaceutical PreparationsIBA 01/2019 - 03/2004
3	Oseltamivir (Tamiflu)FDA Link 06/2017 - 01/2011
2	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 02/2013
2	CytokinesIBA 01/2019 - 12/2015
2	Amino Acids FDA Link 01/2018 - 04/2015
2	difluprednate FDA Link 01/2018 - 01/2018
2	HLA-A*02:01 antigenIBA 01/2018 - 01/2018
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018 - 01/2017
2	Immune Sera (Antisera)IBA 06/2017 - 01/2016
2	NucleoproteinsIBA 11/2016 - 07/2010
2	Viral AntigensIBA 12/2015 - 12/2015
2	Viral HemagglutininsIBA 01/2015 - 01/2013
2	InterferonsIBA 05/2013 - 09/2009
2	PlasminogenIBA 03/2013 - 11/2010
2	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 01/2013 - 07/2008
2	avian influenza A virus hemagglutininIBA 01/2013 - 08/2010
2	Viral ProteinsIBA 07/2010 - 01/2010
2	Glycoproteins (Glycoprotein)IBA 10/2008 - 07/2004
1	COVID-19 VaccinesIBA 12/2021
1	2019-nCoV Vaccine mRNA-1273IBA 12/2021
1	Immunoglobulin G (IgG)IBA 12/2021
1	Dinoprostone (PGE2)FDA Link 01/2021
1	daratumumabIBA 01/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	HLA-B Antigens (HLA-B)IBA 01/2020
1	Cholinergic ReceptorsIBA 01/2019
1	LectinsIBA 01/2019
1	Interleukin-13IBA 01/2019
1	Interleukin-5 (Interleukin 5)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	ChromatinIBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	Immunologic Factors (Immunomodulators)IBA 01/2019
1	Ion Channels (Ion Channel)IBA 11/2017
1	Arginine (L-Arginine)FDA Link 06/2017
1	Inactivated VaccinesIBA 01/2017
1	Monoclonal AntibodiesIBA 12/2013
1	Interferon Type IIBA 05/2013
1	Fibrinogen (Factor I)FDA Link 03/2013
1	Hemostatics (Antihemorrhagics)IBA 03/2013
1	Interferon-gamma (Interferon, gamma)IBA 03/2013
1	FibrinIBA 03/2013
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 02/2013
1	focetriaIBA 01/2013
1	PAR-1-activating peptideIBA 01/2013
1	AerosolsIBA 06/2012
1	Antinuclear AntibodiesIBA 04/2012
1	Green Fluorescent ProteinsIBA 04/2011
1	Amantadine (Aman)FDA LinkGeneric 01/2011
1	Zanamivir (Relenza)FDA Link 01/2011
1	Peptide Hydrolases (Proteases)FDA Link 11/2010
1	Subunit VaccinesIBA 07/2010
1	Complement System Proteins (Complement)IBA 02/2010
1	Virulence Factors (Pathogenicity Factors)IBA 02/2010
1	LigandsIBA 08/2009
1	AM 19IBA 10/2008
1	Biological ProductsIBA 10/2008
1	B 956IBA 07/2008

Therapy/Procedure

4	Therapeutics 01/2019 - 03/2004
3	Immunotherapy 12/2021 - 12/2013
1	Drug Therapy (Chemotherapy) 12/2021
1	Injections 12/2014